New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Babies found to have greater imagination than previously known

Babies found to have greater imagination than previously known

by Central European UniversityCredit: Unsplash/CC0 Public DomainIn a new study published inPhilosophical Transactions of the Royal Society B, scientists from Vienna-based Central European Univer
Pediatrics April 13,2024
Babies found to have greater imagination than previously known

Babies found to have greater imagination than previously known

by Central European UniversityCredit: Unsplash/CC0 Public DomainIn a new study published inPhilosophical Transactions of the Royal Society B, scientists from Vienna-based Central European Univer
Pediatrics April 13,2024
COVID-19 increases the chance of getting an autoimmune condition

COVID-19 increases the chance of getting an autoimmune condition

by Magdalena Plebanski, Rhiane Moody,The ConversationCredit: Unsplash/CC0 Public DomainSARS-CoV-2, the virus that causes COVID-19, can sometimes cause the immune system to mistakenly attack the
Immunology & Rheumatology April 13,2024
COVID-19 increases the chance of getting an autoimmune condition

COVID-19 increases the chance of getting an autoimmune condition

by Magdalena Plebanski, Rhiane Moody,The ConversationCredit: Unsplash/CC0 Public DomainSARS-CoV-2, the virus that causes COVID-19, can sometimes cause the immune system to mistakenly attack the
Immunology & Rheumatology April 13,2024
COVID-19 mutations and their links to excessive immune responses

COVID-19 mutations and their links to excessive immune responses

by King Abdullah University of Science and TechnologySchematic representation summarizing the main findings. The KR mutant SARS-CoV-2 infected patients display high magnitude of immune response.
Immunology & Rheumatology April 13,2024
COVID-19 mutations and their links to excessive immune responses

COVID-19 mutations and their links to excessive immune responses

by King Abdullah University of Science and TechnologySchematic representation summarizing the main findings. The KR mutant SARS-CoV-2 infected patients display high magnitude of immune response.
Immunology & Rheumatology April 13,2024
COVID-19: Biomarkers linked to severe forms of the disease

COVID-19: Biomarkers linked to severe forms of the disease

by University of MontrealColorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image captu
Immunology & Rheumatology April 13,2024
COVID-19: Biomarkers linked to severe forms of the disease

COVID-19: Biomarkers linked to severe forms of the disease

by University of MontrealColorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image captu
Immunology & Rheumatology April 13,2024
How COVID-19 triggers massive inflammation

How COVID-19 triggers massive inflammation

by Children's Hospital BostonSARS-CoV-2 (shown here in an electron microscopy image). Credit: National Institute of Allergy and Infectious Diseases, NIHA study led by researchers at Boston Ch
Immunology & Rheumatology April 13,2024
How COVID-19 triggers massive inflammation

How COVID-19 triggers massive inflammation

by Children's Hospital BostonSARS-CoV-2 (shown here in an electron microscopy image). Credit: National Institute of Allergy and Infectious Diseases, NIHA study led by researchers at Boston Ch
Immunology & Rheumatology April 13,2024
COVID infection may boost antibodies for up to 20 months

COVID infection may boost antibodies for up to 20 months

If you've already had COVID-19, your natural antibodies may last as long as 20 months, a new study suggests.While this is reassuring, experts are quick to caution that the new findings don't n
Immunology & Rheumatology April 13,2024
COVID infection may boost antibodies for up to 20 months

COVID infection may boost antibodies for up to 20 months

If you've already had COVID-19, your natural antibodies may last as long as 20 months, a new study suggests.While this is reassuring, experts are quick to caution that the new findings don't n
Immunology & Rheumatology April 13,2024
A COVID-19 biomarker: Low blood levels of sphingosine predict symptomatic infections

A COVID-19 biomarker: Low blood levels of sphingosine predict symptomatic infections

by Medical University of South CarolinaImage of the ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV). Credit: CDCResearchers remain perplexed as to why some patients
Immunology & Rheumatology April 13,2024
A COVID-19 biomarker: Low blood levels of sphingosine predict symptomatic infections

A COVID-19 biomarker: Low blood levels of sphingosine predict symptomatic infections

by Medical University of South CarolinaImage of the ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV). Credit: CDCResearchers remain perplexed as to why some patients
Immunology & Rheumatology April 13,2024
CRISPR screen reveals loss of genes in interferon gamma receptor signaling pathway

CRISPR screen reveals loss of genes in interferon gamma receptor signaling pathway

by Massachusetts General HospitalGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Researchers at Massachusetts General Hospital (MGH) have discovered that the interferon gamma recept
Immunology & Rheumatology April 13,2024
CRISPR screen reveals loss of genes in interferon gamma receptor signaling pathway

CRISPR screen reveals loss of genes in interferon gamma receptor signaling pathway

by Massachusetts General HospitalGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Researchers at Massachusetts General Hospital (MGH) have discovered that the interferon gamma recept
Immunology & Rheumatology April 13,2024
C-reactive protein reduces the immune response in inflammatory disease

C-reactive protein reduces the immune response in inflammatory disease

by Karin Söderlund Leifler,Linköping UniversityGraphical abstract. Credit:Journal of Autoimmunity(2023). DOI: 10.1016/j.jaut.2023.102998The biological function of the C-reactive prot
Immunology & Rheumatology April 13,2024
C-reactive protein reduces the immune response in inflammatory disease

C-reactive protein reduces the immune response in inflammatory disease

by Karin Söderlund Leifler,Linköping UniversityGraphical abstract. Credit:Journal of Autoimmunity(2023). DOI: 10.1016/j.jaut.2023.102998The biological function of the C-reactive prot
Immunology & Rheumatology April 13,2024
COVID booster vaccines: How a third dose may help vulnerable people 'level up' their immunity

COVID booster vaccines: How a third dose may help vulnerable people 'level up' their immunity

by Nathan Cheetham,The ConversationCredit: Unsplash/CC0 Public DomainCOVID vaccines call our immune systems to action, generating antibodies which fight against any contact we have with the viru
Immunology & Rheumatology April 13,2024
COVID booster vaccines: How a third dose may help vulnerable people 'level up' their immunity

COVID booster vaccines: How a third dose may help vulnerable people 'level up' their immunity

by Nathan Cheetham,The ConversationCredit: Unsplash/CC0 Public DomainCOVID vaccines call our immune systems to action, generating antibodies which fight against any contact we have with the viru
Immunology & Rheumatology April 13,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com